Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
May 16, 2024 08:45 ET
|
Dalrada Financial Corp.
Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
April 23, 2024 08:00 ET
|
Dalrada Financial Corp.
OTCQB: DFCO subsidiary announces entry into the global weight loss drug market currently worth approximately $6 billion